MEDNAX, Inc. (MD)

25.96
NYSE
Prev Close 25.96
Day Low/High 0.00 / 0.00
52 Wk Low/High 25.47 / 53.17
Exchange NYSE
Shares Outstanding 87.87B
Market Cap 2.28B
Div & Yield N.A. (N.A)

Latest News

IIROC Trading Halt - MD

IIROC Trading Halt - MD

VANCOUVER, April 15, 2019 /CNW/ - The following issues have been halted by IIROC: Company: Midland Exploration Inc.

Georgia Neonatology Practice Joins MEDNAX

Georgia Neonatology Practice Joins MEDNAX

MEDNAX, Inc. (NYSE: MD), today announced its affiliation with Georgia Neonatology, LLC, a private neonatology practice based in Athens, Ga.

MEDNAX Announces Board Of Directors Nominees

MEDNAX Announces Board Of Directors Nominees

MEDNAX, Inc. (NYSE:MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today announced the nomination of Carlos A.

MedData's New RCM Technology Solution Accelerates Reimbursement For Providers

MedData's New RCM Technology Solution Accelerates Reimbursement For Providers

MedData, a MEDNAX (NYSE: MD) company and a leading provider of technology-enabled management services for hospitals and healthcare providers, today announced the launch of MedData FastTrack, a tech-infused solution for faster reimbursement.

MEDNAX To Present At Upcoming Investor Conferences

MEDNAX To Present At Upcoming Investor Conferences

MEDNAX, Inc. (NYSE: MD), today announced that it is scheduled to make presentations at two upcoming investor conferences.

MEDNAX Reports Fourth Quarter GAAP EPS Of $0.68; Adjusted EPS Of $0.92

MEDNAX Reports Fourth Quarter GAAP EPS Of $0.68; Adjusted EPS Of $0.92

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today reported earnings of $0.

MEDNAX 2018 Fourth Quarter Conference Call/Webcast Scheduled For Thursday, February 7, 2019

MEDNAX 2018 Fourth Quarter Conference Call/Webcast Scheduled For Thursday, February 7, 2019

MEDNAX, Inc. (NYSE: MD), will host an investor conference call and webcast on Thursday, February 7, 2019 at 10:00 a.

MEDNAX Announces Completion Of $250 Million Accelerated Share Repurchase Program

MEDNAX Announces Completion Of $250 Million Accelerated Share Repurchase Program

MEDNAX, Inc. (NYSE: MD), the national medical group specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric physician services, and management services, today announced that it has completed the $250 million...

MEDNAX To Present At Upcoming Investor Conferences

MEDNAX To Present At Upcoming Investor Conferences

MEDNAX, Inc. (NYSE: MD), today announced that it is scheduled to make presentations at two upcoming investor conferences.

MEDNAX Radiology Solutions Launches Artificial Intelligence Incubator To Stimulate Innovation While Driving Adoption In Radiology

MEDNAX Radiology Solutions Launches Artificial Intelligence Incubator To Stimulate Innovation While Driving Adoption In Radiology

MEDNAX , Inc. (NYSE: MD) and MEDNAX Radiology Solutions, one of the nation's largest radiology practices, has launched the MEDNAX Radiology Solutions Artificial Intelligence (MDR-AI) Incubator.

MEDNAX Continues Its Expansion In Radiology With The Acquisition Of Another Leading South Florida Radiology Practice

MEDNAX Continues Its Expansion In Radiology With The Acquisition Of Another Leading South Florida Radiology Practice

MEDNAX, Inc. (NYSE: MD), a leading physician services and health solutions provider, today announced the acquisition of Bethesda Radiology Associates, Inc.

MEDNAX Radiology Solutions And VRad To Exhibit At RSNA 2018 Annual Meeting Nov. 25-29

MEDNAX Radiology Solutions And VRad To Exhibit At RSNA 2018 Annual Meeting Nov. 25-29

MEDNAX, Inc. (NYSE:MD) and MEDNAX Radiology Solutions, one of the nation's largest radiology practices, which includes vRad (Virtual Radiologic) and leading radiology practices based in Tennessee (Radiology Alliance and Associates in Diagnostic...

MEDNAX Launches Private Offering Of $750 Million Senior Notes Due 2026

MEDNAX Launches Private Offering Of $750 Million Senior Notes Due 2026

MEDNAX, Inc. (NYSE:MD), announced today that it is proposing to issue $750.

MEDNAX To Present At Upcoming Investor Conferences

MEDNAX To Present At Upcoming Investor Conferences

MEDNAX, Inc. (NYSE: MD), today announced that it is scheduled to make presentations at two upcoming investor conferences.

MEDNAX Reports Third Quarter GAAP EPS Of $0.72; Adjusted EPS Of $0.94

MEDNAX Reports Third Quarter GAAP EPS Of $0.72; Adjusted EPS Of $0.94

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today reported earnings of $0.

MEDNAX Announces Acquisition Of Leading Tennessee Radiology Practice

MEDNAX Announces Acquisition Of Leading Tennessee Radiology Practice

MEDNAX, Inc. (NYSE: MD), today announced the acquisition of Associates in Diagnostic Radiology, P.

Interesting MD Put And Call Options For December 21st

Interesting MD Put And Call Options For December 21st

Investors in Mednax, Inc. saw new options become available this week, for the December 21st expiration.

MEDNAX 2018 Third Quarter Conference Call/Webcast Scheduled For Thursday, November 1, 2018

MEDNAX 2018 Third Quarter Conference Call/Webcast Scheduled For Thursday, November 1, 2018

MEDNAX, Inc. (NYSE:MD), will host an investor conference call and webcast on Thursday, November 1, 2018 at 10:00 a.

MEDNAX's American Anesthesiology To Exhibit At The ANESTHESIOLOGY® 2018 Annual Meeting Oct. 13-15

MEDNAX's American Anesthesiology To Exhibit At The ANESTHESIOLOGY® 2018 Annual Meeting Oct. 13-15

MEDNAX, Inc. (NYSE:MD), the national health solutions partner specializing in anesthesiology, neonatology, maternal-fetal medicine, other pediatric services, radiology, and management services, will exhibit at the ANESTHESIOLOGY® 2018 annual meeting...

MEDNAX Announces Acquisition Of Large Neonatology Practice In South Florida

MEDNAX Announces Acquisition Of Large Neonatology Practice In South Florida

MEDNAX, Inc. (NYSE: MD), today announced the acquisition of South Dade Neonatology, a private neonatology practice based in Miami.

Surgical Directions Names Dr. Katherine Grichnik Medical Director And Vice President Of Clinical Development

Surgical Directions Names Dr. Katherine Grichnik Medical Director And Vice President Of Clinical Development

Surgical Directions, a MEDNAX company (NYSE:MD) and leading healthcare consulting firm, is proud to announce Katherine Grichnik, M.

MEDNAX Announces Acquisition Of Leading Nevada Radiology Practice

MEDNAX Announces Acquisition Of Leading Nevada Radiology Practice

MEDNAX, Inc. (NYSE:MD), today announced the acquisition of Radiology Specialists, LTD, a private radiology physician group based in Las Vegas.

MEDNAX Launches Audiology Institute: Nation's Largest Provider Of Newborn Hearing Screen Services Aims To Innovate The Care Delivery Model To Improve Patient Care And Access To Early Hearing Loss Identification, Diagnosis And Intervention

MEDNAX Launches Audiology Institute: Nation's Largest Provider Of Newborn Hearing Screen Services Aims To Innovate The Care Delivery Model To Improve Patient Care And Access To Early Hearing Loss Identification, Diagnosis And Intervention

MEDNAX, Inc. (NYSE:MD), the nation's largest provider of newborn hearing screen services, has launched the MEDNAX Audiology Institute, which will promote innovation and collaboration across all aspects of pediatric hearing loss - early detection,...

September 10th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors Of The Deadline In The Class Action Lawsuit Against MEDNAX, Inc. (MD)

September 10th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors Of The Deadline In The Class Action Lawsuit Against MEDNAX, Inc. (MD)

National securities litigation law firm Glancy Prongay & Murray LLP ("GPM") reminds investors of the  September 10, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased MEDNAX, Inc.

MEDNAX Commences $250 Million Accelerated Share Repurchase Program

MEDNAX Commences $250 Million Accelerated Share Repurchase Program

MEDNAX, Inc. (NYSE: MD), the national medical group specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today announced the commencement of a $250 million accelerated share...

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Mednax, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Mednax, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Mednax, Inc.

MD LOSS NOTICE: Rosen Law Firm Reminds Mednax, Inc. Investors Of Important September 10 Deadline In Class Action

MD LOSS NOTICE: Rosen Law Firm Reminds Mednax, Inc. Investors Of Important September 10 Deadline In Class Action

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Mednax, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Mednax, Inc. - MD

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Mednax, Inc. - MD

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Mednax, Inc.

TheStreet Quant Rating: C (Hold)